hbr.org
The psychology of data visualization.
over 8 years ago
hbr.org
Are companies taking an obsession with health too far?
about 8 years ago
hbr.org
Navigating the blurry line between persuasive and manipulative visualizations.
about 8 years ago
hbr.org
At the social network behemoth, machine learning has become a platform for the platform.
over 6 years ago
hbr.org
The good news: Companies are stopping more attacks than ever before. We bet you can guess the bad news.
over 5 years ago
hbr.org
During the global pandemic, a palpable sense of collective grief has emerged. Grief expert David Kessler says that grief is actually multiple feelings that we must manage. In an interview with HBR, he explains how the classic five stages of grief (denial, anger, bargaining, sadness, acceptance) apply today, and the practical steps we can take to manage the anxiety. Those include balancing bad thoughts with good; focusing on the present; letting go of things you can’t control; and stocking up on…
almost 4 years ago
hbr.org
Many people are seeking ways to deal with their anxiety and grief during the current pandemic. One way that helps is to institute rituals in your day. Harvard Business School Professor Mike Norton has studied rituals and found that those who use them feel better and more in control. Even remembering a ritual from the past can help you in the present. The coronavirus pandemic has both disrupted many rituals — like book clubs or church services — and fostered new ones. Online happy hours and other…
almost 4 years ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freehbr.org
New research shows emotions really can drive stock prices.
about 2 years ago
hbr.org
Covid vaccine producer Moderna has sued fellow vaccine maker Pfizer for patent infringement. The company pledged in 2020 not to enforce its patents as many companies raced to develop a vaccine. But in 2022 it amended this pledge saying it may start enforcing its patents in higher-income countries. Wall Street Journal reporter Peter Loftus, the author of a book on Moderna, is not surprised by this move and says it is a signal of a return to business as normal in the biotech industry. Loftus answe…
over 1 year ago